GH — Guardant Health, Inc.

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1576280 ·
Last close
$178.36
Market Cap
$23.94B
52W High
$183.51
52W Low
$60.45
ADV30
1,864,523
Next earnings
2026-10-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 334,978,000 219,029,000 -129,118,000 -120,142,000 1,912,294,000 1,053,469,000 2,135,161,000
Mar 2026 301,665,000 196,746,000 -121,350,000 -112,075,000 1,915,291,000 989,291,000 2,096,364,000
Dec 2025 281,266,000 181,774,000 -120,805,000 -128,494,000 2,013,659,000 378,203,000 2,112,966,000
Sep 2025 265,196,000 171,609,000 -98,989,000 -92,725,000 1,276,786,000 580,013,000 1,631,259,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-185,187,000
Investing CF
$-118,526,000
Financing CF
$737,796,000
CapEx
$-55,537,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-3.49
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$-3,226,729,000
Inventory
$105,463,000
Receivables
$144,249,000
ST Investments
$0
EBIT TTM
$-449,654,000
Pretax Income TTM
$-454,470,000
Interest Exp TTM
$4,816,000
Analysts
24

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,183,105,024
EBITDA
$-430,571,008
Free Cash Flow
$26,607,000
Enterprise Value
$21,763,338,240
Total Cash
$1,053,468,992
Total Debt
$1,697,012,992
Shares Out
134,196,170
Trailing EPS
$-3.51
Book Value
$-1.67
ROE
—
ROA
-18.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 982,021,000 -437,248,000 -416,277,000 2,013,659,000 2,112,966,000 -99,307,000 -184,760,000
Dec 2024 739,016,000 -443,594,000 -436,373,000 1,485,609,000 1,625,256,000 -139,647,000 -239,858,000
Dec 2023 563,948,000 -564,725,000 -479,449,000 1,786,421,000 1,627,737,000 158,684,000 -324,975,000
Dec 2022 449,538,000 -544,378,000 -654,588,000 1,609,985,000 1,549,805,000 60,180,000 -309,463,000

TTM Snapshot

Revenues TTM
$655,381,000
NetIncome TTM
$-451,009,000
OpCashFlow TTM
$0
Assets (Latest)
$2,013,659,000
Forward EPS
$-0.40

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $175.00 · spot: $178.36 · call volume: 64 · put volume: 824

Peers — same industry

TickerNameMarket CapLastDaily %
LH LABCORP HOLDINGS INC. $24.99B $308.11 —
DGX QUEST DIAGNOSTICS INC $25.72B $233.07 —
THC TENET HEALTHCARE CORP $20.58B $255.56 —
EHC Encompass Health Corp $11.99B $121.49 —
FMS Fresenius Medical Care AG $11.91B $22.38 —

News headlines (Yahoo Finance, 1h cache)

FDA Advisors Said It Should Approve the Grail Multicancer Blood Test. The Stock Rises Sharply.
2026-09-24 14:52 · Yahoo
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why.
2026-09-21 20:00 · Yahoo
Guardant Health (GH) Lands First FDA Cleared Breast Cancer Liquid Biopsy Role
2026-09-18 05:14 · Yahoo
Guardant Health Nears Buy Point As Sales Outlook Brightens
2026-09-16 16:39 · Yahoo
Dow Jones Futures Rise As Oil Prices, Yields Fall Before Fed Rate Hike; Will Market Rally Bid Bond Voyage?
2026-09-16 12:07 · Yahoo
Guardant Health’s Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
2026-09-14 20:05 · Yahoo
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
2026-09-09 19:46 · Yahoo
What Makes Guardant Health (GH) a Compelling Bet?
2026-09-08 13:22 · Yahoo
Abbott launches Freenome’s colorectal cancer screening test
2026-09-30 14:58 · Yahoo
Cathie Wood Makes a Big AI Bet and Cuts Bitcoin Exposure
2026-09-21 19:23 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.